Question Bank › Staircase quarter: best recent period just repor

Staircase quarter: best recent period just reported, and the next step up is already in hand

Calls Tested
457
Answered YES
4
Hit Rate
0.9%
rare by design

ChromaDex Corporation (CDXC) — this company's answers

NO on the Q4 2021 call 2022-03-09 C+
The model's full reasoning — Q4 2021 call → NOWe need answer only YES or NO. Need analyze transcript. Need determine if management presents just-reported period as strongest recent stretch AND next period bigger with reasons in hand. Let's parse. Q4 2021 results. Management statements: Rob Fried: "In 2021, ChromaDex achieved several important strategic milestones... delivered solid financial performance in 2021. Full year net sales $67.4M, 14% increase... Tru Niagen net sales $56.7M, 20% increase... gross margins 61.5%, 200 bps increase... despite challenging supply chain." "I believe we're at an inflection point... litigation largely behind us... devoting more resources..." Q4 total operating loss improved. "In fourth quarter, we tested TV advertising... new TV commercials begins very nationally in March." "recent scientific developments significant... validate market opportunity." "We're beginning to test benefit specific messages... encouraging results." "launching new Tru Niagen product this year... I'm excited to share more once it's in the market." "new strategic partner Designs for Health... Sinopharm... finalizing commercial plans and supply agreement... expect them to contribute to increased sales in 2022." "For established relationships like Nestle, in discussions..." "more confident than ever about market opportunity." Kevin Farr: "delivered on or exceeded our latest full year 2021 financial outlook... total net sales $67.4M, 14% increase with strong growth in Tru Niagen 20%, including 21% growth in e-commerce. Gross margins 61.5%, up 200 bps... roughly flat R&D... higher selling and marketing... slight decrease in G&A... adjusted EBITDA excluding legal expense posted full year loss $2.5M vs loss $1M in 2020. Increased loss primarily driven by increased brand investments... litigation behind us, focusing on adjusted EBITDA including legal expense." Q4: "solid quarter with total net sales $17.8M, up 15% year-over-year and gross margin 61.2%. adjusted EBITDA excluding legal expense loss $1.8M." "new Tru Niagen commercial will be soon airing on national TV. Given current macroeconomic environment, expect to scale new brand campaign in pragmatic fashion in 2022." Then sequential P&L: Q4 net sales up 3% vs Q3. Tru Niagen net sales down 5% sequentially. Sales to Monte Cana impacted by COVID restrictions in Australia delayed rollout. Watsons sales $2.2M vs $2.6M Q3. E-commerce up 6% sequentially.

← Back to the full CDXC analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that the PERIOD DIRECTLY AHEAD IS SET TO BE BIGGER STILL, grounding that near-term step-up in things the company ALREADY HAS IN HAND rather than in hopes about the market? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent staircase pattern with BOTH halves present: (1) THE PERIOD JUST FINISHED WAS A HIGH POINT, IN MANAGEMENT'S OWN TELLING. Management characterizes the recent period's business — its orders, volumes, customers, activity, output, wins, or overall performance — as among the strongest the company has recently produced: a record or near-record stretch, a clear high-water mark versus the company's own recent past, or plainly described as the best the business has been running in a long while. The strength must be about real activity that already happened, in whatever terms fit the industry, and must be management's own framing rather than a number an analyst characterizes as strong. (2) THE VERY NEXT STRETCH IS DESCRIBED AS BIGGER, FOR REASONS ALREADY IN HAND. Management indicates that the period immediately ahead — the coming quarter, season, or comparable near-term stretch — is expected to step ABOVE the high point just reported, and supports that expectation with things that already exist or are already committed: orders or bookings already received, work already sold or scheduled, customers already ramping, capacity or product already coming online, commitments already signed, or activity already running at a higher pace than the reported period's average. The essence is that the next step of the staircase is already under the company's feet — management can point to it — rather than something that requires demand to improve, markets to recover, or new business to be won first. Answer NO if the reported period is weak, mixed, merely in-line, or only recovering toward past levels, with no recent high point in management's own framing. NO if management describes the strong period as a peak, one-time bulge, pull-forward, or level it expects to come back down from. NO if the next period is guided flat, down, or merely 'continued strong' without a described step above the level just reported. NO if the expected step-up rests mainly on hoped-for demand, seasonality alone, market recovery, pipeline conversion, or deals not yet closed rather than on business or capability already in hand. NO if either half appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+
GPOR Gulfport Energy Corporation Q4 2016 2017-02-14 A
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

GPOR · Q4 2016 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES The transcript shows management framing 2016 as a defining year with record production growth (32% YoY) and reserves increases, calling it a high point in their own words ("another year of record production growth"). For 2017, they announce a $1B–$1.1B capital budget 45–53% higher production growth, grounded in the SCOOP acquisition (already closed or closing), doubled Utica rig count, and existing acreage/hedges—not market hopes. They also note Q1 2017 activity ramping to four net wells turned-to-sales.
UPLD · Q4 2017 → YESThe question is: Does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that...YES Management frames Q4 as an "incredibly strong close" with a "record 44% revenue growth" and 1,300-basis-point EBITDA margin expansion to 35%, calling it the 14th consecutive quarter of beating guidance and part of an "outstanding year.
HPP · Q4 2015 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES Victor Coleman explicitly frames 2015 as a “banner year” and “landmark year” with “strong fourth quarter earnings,” “all-time high” demand in Q4, and “impressive” results that “rounded out” the year.

More from the question bank

Selling the shovels to a customer who just gCheap-to-serve incremental businessConviction backed by things in handQ&A has flipped from problems to possibilitiRoom to raise the ceilingBreak from their own historyAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.